[Diagnostic and treatment results in small-cell lung cancer detected during dispensary care].
The study was concerned with evaluating diagnosis and treatment for small-cell cancer of the lung in 75 patients who had been followed up for long periods of time before tumor detection. Methods of monitoring healthy populations as well as those at risk for lung cancer are discussed. Small-cell carcinoma was identified in 18.1%. Prophylactic fluorography of the chest conducted once a year was shown to fail to assure timely identification of small-cell cancer of the lung in most patients. An extra yearly X-ray examination of those at risk was followed by a rise in the percentage of actively--identifiable small-cell lung tumors to 66.7 while tumors detected on presentation--to 25%. Survival in small-cell lung cancer patients was studied and its median was established at 22 months in stage I--II patients given specialized antitumor treatment, 16 months in stage III and 7 months in stage IV.